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Abstract
Non-echoplanar diffusion weighted magnetic resonance im-
aging (DWI) has established itself as the modality of choice in
detecting and localising post-operative middle ear cleft
cholesteatoma. Despite its good diagnostic performance, there
are recognised pitfalls in its radiological interpretation which
both the radiologist and otologist should be aware of. Our
article highlights the various pitfalls and provides guidance
for improving radiological interpretation and navigating be-
yond many of the pitfalls. It is recommended radiological
practice to interpret the diffusion weighted images together
with the ADC map and supplement with the corresponding
T1 weighted and T2 weighted images, all of which can con-
tribute to and enhance lesion localisation and characterisation.
ADC values are also helpful in improving specificity and con-
fidence levels. Given the limitation in sensitivity in detecting
small cholesteatoma less than 3 mm, serial monitoring with
DWI over time is recommended to allow any small residual
cholesteatoma pearls to grow and become large enough to be
detected on DWI. Optimising image acquisition and
discussing at a joint clinico-radiological meeting both foster
good radiological interpretation to navigate beyond the pitfalls
and ultimately good patient care.
Teaching Points
• Non-echoplanar DWI is the imaging of choice in detecting
post-operative cholesteatoma.
• There are recognised pitfalls which may hinder accurate
radiological interpretation.
• Interpret with the ADC map /values and T1W and T2W
images.
• Serial DWI monitoring is of value in detection and
characterisation.
• Optimising image acquisition and discussing at clinico-
radiological meetings enhance radiological interpretation.
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Introduction
Since it was first described in 2006 for the detection of
cholesteatoma [1, 2], non-echoplanar diffusion weighted
magnetic resonance imaging (DWI) has now firmly
established its role as the imaging modality of choice in
detecting post-operative cholesteatoma [3–7]. It has super-
seded CT, echoplanar DWI and delayed contrast MRI by
virtue of its superior diagnostic performance [3–8]. Non-
echoplanar DWI is capable of acquiring thin slices (as
thin as 2 mm) and generating a high resolution matrix,
and hence can detect cholesteatoma as small as 2 mm
[3–5]. It also has the advantage of not requiring intrave-
nous gadolinium contrast, which is implicated with
nephrogenic systemic fibrosis [9] and intracerebral depo-
sition [10]. It also does not require delayed scans as with
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delayed contrast MRI [3]. Even though echoplanar DWI
has a shorter acquisition time, non-echoplanar DWI per-
forms better than its echoplanar counterpart primarily due
to the lack of air-bone susceptibility artefact and distortion
at the temporal bones [3, 6]. It offers the potential to
reduce the number of mandatory second-look (or re-
look) surgery in detecting residual or recurrent disease
[3, 5, 7]. However, the limitations of the technique still
need to be considered as part of a safer and cost-effective
work-up strategy. This article aims to highlight pitfalls of
radiological interpretation and empower the reader with
necessary approaches to navigate beyond the pitfalls.
Optimisation of technique
By virtue of its keratin content, cholesteatoma returns high
signal intensity compared to brain tissue on the diffusion
weighted images obtained both at b values of 0 s/mm2 and
at higher values of 800 or 1000 s/mm2 (Fig. 1). This is due to a
combination of restricted diffusion and T2 shine-through ef-
fect. It returns low signal on the apparent diffusion coefficient
(ADC) map [3, 4, 9]. The ADCmap is free from any T1 or T2
effects, provides a true quantitative display of water diffusivity
at each voxel [11], and is integral in the interpretation of the
DWI images [3, 12]. Non-cholesteatomatous soft tissue such
as granulation tissue, inflammation, and fluid return lower or
no signal on the high b value (b800 or b1000) images com-
pared to the b0 images and consequently high signal on the
ADC map (Fig. 2).
To allow accurate radiological interpretation, the DWI im-
ages need to be optimal in the first instance. The non-
echoplanar technique can generate image slices without air-
bone susceptibility artefacts and distortion, as thin as 2–3 mm
producing a high resolution matrix, which is essential for the
detection of tiny cholesteatoma pearls (Fig. 3). Current non-
echoplanar sequences broadly include single-shot turbo spin-
echo (SSTSE) sequences [such as HASTE (half Fourier
SSTSE) [13–19]] and multishot turbo spin-echo (MSTSE)
sequences [such as with PROPELLER (periodically rotated
overlapping parallel lines with enhanced reconstruction)
[20–23]]. Currently, slice thickness as low as 2 mm can be
acquiredwith HASTE and 3mmwith PROPELLERDWI [4].
The SSTSE sequence such as HASTE acquire one b value at a
time (currently 5 to 6 min for each b value) and are susceptible
to both movement artefacts and slice position misregistration
errors in post-acquisition ADC map calculation. In contrast,
the multidirectionally acquired sequences, however, can ac-
quire two b values in a single acquisition (currently under
5 min with multishot PROPELLER DWI), and hence theoret-
ically quicker and less susceptible to motion artefacts and slice
position misregistration errors than HASTE [4]. The MSTSE
sequences have a shorter echo train than their single shot
counterparts and hence are able to mitigate the T2 blurring
effects (image degradation due to T2 decay during acquisi-
tion) [24]. As a SSTSE sequence, but using a half-Fourier
acquisition, HASTE is also able to reduce the effect of T2
blurring. With most types, non-echoplanar diffusion weighted
images can be acquired in any plane. Currently, with the
PROPELLER DWI sequence, the images can currently only
Fig. 1 Typical MRI
characteristics of post-operative
cholesteatoma. Coronal images
through the left mastoid remnant
shows the lesion (white arrow) as
high signal on a the T2 weighted
image, b DWI b0 image, and c
DWI b1000 image and a low
signal on the d ADC map and e
non-contrast enhanced T1
weighted image. f Surgery
confirms the presence of the
cholesteatoma. The keratin has
been suctioned away showing the
underlying white squamous
epithelium lining the mastoid
remnant (white arrow) and aditus
(star)
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be acquired in the axial plane [3, 4, 20, 23], but it can be
reconstructed in other planes [21]. Three dimensional (3D)
DWI acquisition with multiplanar reconstruction has also
been described with TFE-DSDE [Turbo field-echo with
diffusion-sensitized driven equilibrium] [25]. In our institu-
tion, the coronal images are preferred as it demonstrates the
tegmen and the relevant tympanomastoid anatomy better for
more confident localisation of disease and surgical planning.
Ideally, the DWI sequences should be supplemented by con-
ventional T2 weighted and T1 weighted images of similar
slice thickness and slice positions to the DWI images to obtain
the anatomical information required for better localisation of
disease. On conventional MRI, cholesteatoma typically
returns high signal on the T2 weighted MR images and low
signal on the T1weightedMR images (Fig. 1) [3]. Though not
specific, these sequences, together with the DWI sequences,
can help further characterise the disease and detect
cholesteatoma more accurately [4]. Supplementing with
post-gadolinium enhanced contrast scan is not necessary as
it does not confer greater diagnostic performance than non-
echoplanar DWI alone [8].
Typically, two b values are sufficient to generate the ADC
map, which is reconstructed following acquisition of the scans
[12]. More b values can be used to strengthen further the ADC
map, but would incur a longer scanning time and a higher risk
of patient movement during scanning and image misregistra-
tion. Crucially, for non-multidirectionally acquired sequences
(such as HASTE), which require separate acquisitions for
each b value, the measurement parameters and the slice posi-
tions for the various b values have to be identical (copy-
referenced) to promote better image registration and genera-
tion of the ADC map. Getting the patient to co-operate by
keeping still during DWI scanning is vital for achieving good
slice registration and image quality.
Quantitative assessment with ADC values
Cholesteatomas have been shown to have a significantly
lower ADC value than non-cholesteatomatous soft tissue
[12]. The threshold ADC values for differentiating the tis-
sue types need to take into account data acquisition param-
eters [12, 26]. Once the ADC threshold is established for
the scanner and the scanning protocol, it performs well in
discriminating cholesteatoma from non-cholesteatomatous
Fig. 2 Typical DWI appearance of non-cholesteatomatous soft tissue.
Coronal images through the right post-operative mastoid remnant
shows the soft tissue (white arrow) as high signal on a the b0 image,
but loses signal on b the b1000 image, and hence demonstrates high
signal on c the ADC map. Surgery confirms granulation tissue
Fig. 3 DWI appearance of a
small residual cholesteatoma
confirmed on second-look
surgery. The a b0 and b b1000
image shows a small 5 mm high
signal cholesteatoma (white
arrow) at the right epitympanum.
It returns low signal on c the
corresponding ADC map, high
signal on d the T2 weighted
image and low signal on e the
non-contrast enhanced T1
weighted image
Insights Imaging (2016) 7:669–678 671
soft tissue with comparable sensitivity and marginally
higher specificity than the qualitative method and can help
navigate beyond some radiological interpretation pitfalls
[12]. The ADC value can be measured by simply placing
on the ADC map a region of interest (ROI) on the lesion,
preferably on an image section that demonstrates the lesion
with the highest contrast. For a more accurate measure-
ment, a freehand ROI can be used and contoured around
the inner border of the central aspect of the lesion to avoid
the edges and partial volume averaging, and a median of
several ADC values is obtained [12, 26] (Fig. 4). When
residual lesions are small and seen only on two contiguous
sections, the mean ADC value can be taken from the two
sections for a more representative value [12, 26].
Diagnostic performance in detecting post-operative
cholesteatoma
Following canal wall up mastoidectomy, a mandatory second-
look surgery is performed 9–12 months later to detect residual
disease. This is because the current literature suggests that
canal wall up procedures are associated with rates of residual
and recurrent disease of anything up to 36 and 18 %, respec-
tively [3, 27, 28].
There are many studies to date that have evaluated the
performance of non-echoplanar DWI in detecting post-
operative cholesteatoma [2, 8, 12–23, 25, 29–39]. They are
all observational studies with some studies havingmixed post-
operative and primary cholesteatoma cases in their study sam-
ples. The studies include both prospective cohort and retro-
spective studies, with sample sizes up to 158 patients [38].
The vast majority of the studies demonstrate a sensitivity
Fig. 4 Measuring the ADC value of a lesion. a As the lesion was better
seen on the b1000 image, a freehand region of interest (ROI) was contoured
around the inner border of the lesion. An image was selected so the central
part of the lesion was measured to avoid partial volume averaging. The
software then maps the ROI on b the corresponding ADC map where the
ADC value is automatically calculated ADC value 846 x 10-6 mm2/s. For
accuracy, this can be repeated several times and a median reading obtained.
In some cases, if the lesion is well seen on the ADC map, the ROI can be
placed directly on the map for ADC value calculation
Fig. 5 False negative case for
cholesteatoma on DWI. a, b A
small 2 mm cholesteatoma pearl
(white arrow) was found on
surgery in the hypotympanum
(star denotes posterior canal
wall), but was not depicted on c
the corresponding 2 mm thick
coronal b1000 image or d T2
weighted image
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and specificity between 80 and 100 % in detecting middle ear
cholesteatoma. A previousmeta-analysis of 10 studies in 2013
reported a sensitivity and specificity of 94 % in detecting
middle ear cholesteatoma [5].
The high diagnostic performance of DWI in detecting post-
operative cholesteatoma lends support for a non-invasive al-
ternative for reliably detecting post-operative disease. Apart
from detecting post-operative cholesteatoma, DWI has also
been shown to correlate well with surgery in depicting size
and location of the disease [18]. It therefore provides useful
information for both operative planning and patient counsel-
ling. Despite its high diagnostic performance, the technique is
associated with some pitfalls in image interpretation attributed
by limitations in the technique, variability in the nature and
behaviour of cholesteatoma and characteristics and complex-
ity of the reconstructed post-operative anatomy.
Pitfalls in sensitivity
A high sensitivity is clinically more desirable than a high
specificity if DWI were to replace mandatory second-look
surgery as i t wi l l reduce res idual or recurrent
cholesteatomas from being missed. The studies have
shown consistently reported that DWI is limited in its
ability to detect small cholesteatoma pearls less than
3 mm (Fig. 5). Occasionally slightly larger cholesteatoma
up to 5 mm can be missed, presumably due to the nature
of the cholesteatoma (lack of necessary keratin to return
Fig. 6 Value of monitoring DWI scans which are negative for the
presence of post-operative cholesteatoma. A year following right canal
wall up surgery, the DWI scan was negative as shown by the a coronal
b1000 image. The patient opted for monitoring with DWI instead of
second-look surgery as his ear was dry. b A follow-up DWI scan a year
later showed residual cholesteatoma (white arrow), which was confirmed
on subsequent surgery
Fig. 7 Case of wax in the ear canal (white arrow) mimicking residual
disease. The a b1000 image shows parallel high signal, which
corresponded to wax in the adjacent ear canal, localised better on b the
corresponding non-contrast enhanced T1 weighted image
Fig. 8 False positive case of proteinaceous fluid in the mastoid remnant.
The coronal a b1000 image shows a small focus of high signal (white
arrow) postero-medially at the mastoid remnant, which returned low
signal on the ADC map, but was distant from the site of the original
middle ear cholesteatoma which was excised with high surgical
confidence. At the clinico-radiological meeting, it was decided to
monitor this annually with DWI. b The subsequent coronal b1000
image showed the high signal focus (white arrow) remained unchanged
over 2 years making it more unlikely to represent residual disease. c The
corresponding non-contrast enhanced T1 weighted image showed the
lesion (white arrow) returned high T1 signal suggestive of
proteinaceous fluid given its stability
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high DWI signal or poor image quality (movement arte-
fact) [3, 18, 38] . There are a few studies in the literature
with lower reported sensitivities than expected, this being
attributed to a larger proportion in their study sample of
cholesteatoma less than 3 mm in size [17, 29]. In addition,
no difference was demonstrated between the performance
using a 3T scanner [17, 25] and a 1.5T scanner, both
equally limited in reliably detecting cholesteatomas less
than 2–3 mm. Other less common causes of false negative
cases described in the current literature include auto-
atticotomy (an epithelial lined sac) [8, 23, 29, 32], aspi-
ration of cholesteatoma on microsuction [23], and patient
movement artefacts [37].
Navigating past the pitfalls in sensitivity
Avoiding a second-look or re-look surgery with a non-
invasive technique such as DWI has financial benefits
and the advantage of reducing surgical morbidity [3].
Despite the high diagnostic performance of DWI, the in-
ability of a negative DWI scan to entirely exclude the
presence of a small cholesteatoma impacts its potential
to replace mandatory second-look surgery. When faced
with a negative DWI, the decision to perform second-
look surgery depends on many factors, including current
clinical/otoscopic signs, the extent of initial disease and
clinical confidence in surgical clearance at initial surgery,
patient preference, and other risk factors of surgery such
as patient’s age and co-morbidity [3]. Several authors
have proposed a reasonable approach such as replacing
second-look surgery in low-risk cases and following them
up with serial annual DWI over a reasonable length of
time [3, 18, 38]. This will allow time for any small unde-
tected cholesteatoma to grow and accumulate keratin to
become sufficiently large to be detectable on DWI
(Fig. 6). A recent study demonstrated that in patients with
a negative first post-operative follow-up DWI and no clin-
ical signs of post-operative cholesteatoma, a repeat
second-follow up scan (performed at least 6 months after
first follow-up DWI) was positive or equivocal for disease
in 14 out of 45 (31 %) ears, with five ears having
cholesteatoma confirmed on surgical exploration [40]. In
addition, 2 third-follow-up DWI scans, which were previ-
ously negative, turned positive for cholesteatoma and was
confirmed on surgery. It is, however, currently unclear
what the optimal length and frequency should be for serial
follow-up imaging with DWI, and this is still subject of
research and discussion. The main drawback to this imag-
ing strategy is the loss of patient to follow-up [3, 18].
Keeping scanning time as short as possible, briefing
the patient on the importance of keeping still during scan-
ning and the use of sedation usually helps prevent or
reduce movement artefacts and misregistration errors in
ADC map calculation [38].
Fig. 9 False positive high DWI signal for cholesteatoma. Non-
cholesteatomatous tissue (surgically confirmed non-specific
inflammation) at the post-operative mastoid remnant, which
demonstrated a high signal (white arrow) on the b1000 image
suggestive of residual cholesteatoma. However, b the corresponding
ADC map demonstrated borderline high ADC signal (white arrow) and
value not supporting the diagnosis of residual cholesteatoma. This case
could also have been resolved with a follow-up DWI scan
Fig. 10 False positive high DWI signal for cholesteatoma. a The coronal
b1000 image shows high signal at the epitympanum, which raised
suspicion for residual cholesteatoma. However, b the corresponding
non-contrast enhanced coronal T1 weighted image showed high signal
(white arrow) and the ADC map intermediate signal and value, both not
supporting the diagnosis of cholesteatoma. Surgery confirmed non-
specific inflammation with no cholesteatoma
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Pitfalls in specificity
There is a myriad of false positive cases described in the lit-
erature for detecting cholesteatoma using non-echoplanar
DWI. Commonly in our experience, wax (Fig. 7) or protein-
aceous fluid (Fig. 8) /cysts and non-specific inflammation
(Figs. 9 and 10) can return high signal on the b1000 images
[3, 12, 22, 23, 32, 35, 38]. They can also be a result of oper-
ative materials such as silastic sheet, bone dust/powder [2, 20,
35], and (calcified) cartilage [38]. There are reports of false
posit ive cases from dental braces artefacts [17],
tympanosclerosis [38], cholesterol granuloma [22, 38], and
squamous cell carcinoma of the external auditory canal [35].
Navigating past the pitfalls in specificity
To improve diagnostic performance including specificity, im-
age interpretation should be performed in a clear clinical con-
text and not in isolation. A useful way to resolve disconcordant
or questionable DWI high signals is for the radiologists to dis-
cuss with the otologists, ideally in a joint clinico-radiological
meeting. The treatment history, such as type of operation(s)
performed and when, the materials used, surgical confidence
of clearance, the extent of initial disease (small pearl in the
epitympanum or extensive disease into the mastoid) and current
ear status (discharging or quiet), and examination are all rele-
vant and important clinical factors to consider. A small focus of
dependant high b1000 signal and restricted diffusion posteriorly
at the mastoid is unlikely to represent a cholesteatoma pearl if
the initial primary disease was a small epitympanic
cholesteatoma which was easily and confidently removed on
surgery. Indeterminate DWI signals of low radiological and
surgical suspicion for cholesteatoma can easily be followed
up with DWI over time to ensure stability or resolution and
hence exclude the possibility of cholesteatoma with more cer-
tainty (Fig. 8). In addition, by providing feedback to the radiol-
ogists following surgery, learning is reinforced and hence better
and more confident radiological interpretation is nurtured.
Supplementing qualitative analysis of the DWI images and
ADCmap with other MRI sequences and ADC values can also
help improve specificity [12]. Quantitative analysis using ADC
Fig. 11 Indeterminate appearance
of residual cholesteatoma: Value of
ADC. The coronal a T2 weighted
and b b0 DWI images show a
small focus of high signal soft
tissue at the left hypotympanum,
which returns just mildly high
signal relative to brain tissue on c
the b1000 DWI image, raising the
possibility of a residual pearl
(similar to Fig. 9a). d The ADC
map demonstrates low signal and
value compatible with
cholesteatoma, thereby increasing
observer confidence. e This was
later confirmed as a 3–4 mm
cholesteatoma at the left
hypotympanum on second-look
surgery
Fig. 12 Value of non-contrast enhanced T1 weighted images. False
positive high DWI signal (white arrow) for cholesteatoma was seen on
a the b1000 image. b The non-contrast enhanced T1 weighted image
showed this (white arrow) to represent subcutaneous tissue just outside
the reconstructed post-operative middle ear cleft. Otoscopic examination
of the area is normal and following discussion at the clinicoradiological
meeting, a follow-up DWI was arranged. This showed stable appearance
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values can provide insight into the nature of the indeterminate
lesions because cholesteatoma typically produces significantly
lower ADC values than non-cholesteatomatous soft tissue in-
cluding granulation tissue, proteinaceous fluid or inflammation
[12] (Figs. 9 and 10). Not infrequently, the cholesteatoma pearls
formed from residual disease are not large enough to return the
characteristic higher signal than brain tissue on the b1000 image
and instead return intermediate or borderline high signal
Fig. 13 Using DWI following
canal wall down surgery. In a
patient who presented with
persistent otorrhoea after CWD
surgery, a the DWI b1000 images
show high signal in the mastoid
remnants bilaterally, which
corresponded to infected debris/
wax on clinical inspection. b On
direct clinical inspection of the
left mastoid remnant, which
showed the infected debris/wax
(white arrow), a bony defect
(black arrow) is noted on the




deep in the petrous apex, which
was demonstrated by high signal
soft tissue (white arrow) on the
coronal c T2 weighted and d
b1000 images
Fig. 14 Using DWI following
canal wall down surgery. a DWI
b1000 image depicted residual
disease (white arrow) at the
mastoid tip, also seen as low
signal on the b corresponding
non-contrast enhanced T1
weighted image and a
heterogenous, but predominantly
high signal on the c T2 weighted
image. d Surgical exploration
confirmed residual cholesteatoma
pearl (white arrow) walled off in
the mastoid tip and was not
readily visible on direct
inspection at the preceding
follow-up clinic. The lesion also
had low ADC signal and value
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(Fig. 11). They can pose a diagnostic challenge, but corroborat-
ing with its ADC value can help improve the observer’s confi-
dence level in detecting cholesteatoma [12]. T1-weighted im-
ages may also help in improving specificity of the DWI images,
as some proteinaceous fluid or non-cholesteatomatous soft tis-
sue including cholesterol granuloma can return high T1W sig-
nal which is not associated with cholesteatoma [4] (Figs. 8, 10,
and 12). The location and configuration of the lesion is also
informative. Wax in the ear canal can return linear (often paral-
lel) high signal changes on the b1000 images and low signal
and values on the ADC map (Fig. 7). As they can depict anat-
omy better than the DWI images, the T1Wand T2Wimages are
especially useful in improving localisation of the lesion and
assessing whether spurious DWI high signals mimicking pos-
sible cholesteatoma actually lie within or outside the post-
operative middle ear cleft (Figs. 7 and 12). Fusion of DWI
images with high resolution CT images can depict clearer
localisation of DWI signal of post-operative cholesteatoma in
relation to the bony anatomy and aid in surgical planning [41],
but this would incur additional radiation exposure.
Use of DWI following canal wall down surgery
The risk of residual or recurrent disease following canal wall
down (CWD) mastoidectomy is much lower than that of canal
wall up mastoidectomy [3, 5]. When accumulating keratin oc-
curs within a mastoid cavity, it can often be readily detected and
successfully cleared with microsuction in an outpatient setting.
In addition, wax has a tendency to accumulate in a CWD mas-
toid cavity, and this can cause false positive signals on DWI
(Fig. 13a). However, there are instances where DWI is especially
valuable when disease is not readily visible on otomicroscopic
examination, such as disease extension into the petrous apex
(Fig. 13) or mastoid tip (Fig. 14), disease deep to an obliterated
cavity, in a small reconstructed middle ear cavity or medial to an
opaque tympanic membrane reconstruction [42]. Close commu-
nication between the radiology and otology teams, with clear
clinical information, and a clear indication for imaging is crucial.
Use of DWI in children
CWU surgery is preferred in children because it obviates the
potential requirement for lifelong ear care, improves the fitting
of hearing aids when required, and is less likely to lead to
otorrhoea associated with swimming [3]. Cholesteatoma in
children, however, is more aggressive than adult disease and
has a higher rate of recurrent and residual disease post-
operatively [43] and the otologist is more inclined to perform
mandatory second-look surgery to detect disease. Having said
this, a recent large prospective observational study comparing
154 adult cases with 54 paediatric cases in detecting post-
operative disease, showed similar good diagnostic perfor-
mance between the two groups [38]. Hence, clinically, DWI
can be considered effective in a paediatric setting as in an adult
setting, in which many otologists will have more experience.
By avoiding radiation exposure and administration of intrave-
nous contrast medium, DWI is especially attractive for imag-
ing children. However, children are less likely to be tolerant of
MRI scanning and may require sedation. In our experience,
successful scanning can be achieved without the need for se-
dation, if the clinician explained the essentials of the proce-
dure to the parent and child beforehand.
Conclusion
Even though non-echoplanar DWI has a high diagnostic perfor-
mance in detecting post-operative cholesteatoma, it is not with-
out limitations. The pitfalls of image interpretation need to be
recognised and managed appropriately by both radiologists and
otologists for it to contribute to effective and safer patient care.
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